These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12209041)

  • 1. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
    Gottesdiener K; Schnitzer T; Fisher C; Bockow B; Markenson J; Ko A; DeTora L; Curtis S; Geissler L; Gertz BJ;
    Rheumatology (Oxford); 2002 Sep; 41(9):1052-61. PubMed ID: 12209041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
    Zacher J; Feldman D; Gerli R; Scott D; Hou SM; Uebelhart D; Rodger IW; Ozturk ZE;
    Curr Med Res Opin; 2003; 19(8):725-36. PubMed ID: 14687444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
    Curtis SP; Bockow B; Fisher C; Olaleye J; Compton A; Ko AT; Reicin AS
    BMC Musculoskelet Disord; 2005 Dec; 6():58. PubMed ID: 16321158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.
    Puopolo A; Boice JA; Fidelholtz JL; Littlejohn TW; Miranda P; Berrocal A; Ko A; Cichanowitz N; Reicin AS
    Osteoarthritis Cartilage; 2007 Dec; 15(12):1348-56. PubMed ID: 17631392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
    Leung AT; Malmstrom K; Gallacher AE; Sarembock B; Poor G; Beaulieu A; Castro R; Sanchez M; Detora LM; Ng J
    Curr Med Res Opin; 2002; 18(2):49-58. PubMed ID: 12017209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.
    Wiesenhutter CW; Boice JA; Ko A; Sheldon EA; Murphy FT; Wittmer BA; Aversano ML; Reicin AS;
    Mayo Clin Proc; 2005 Apr; 80(4):470-9. PubMed ID: 15819283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
    van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M
    Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
    Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S;
    J Rheumatol; 2002 Aug; 29(8):1623-30. PubMed ID: 12180720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
    Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.
    Reginster JY; Malmstrom K; Mehta A; Bergman G; Ko AT; Curtis SP; Reicin AS
    Ann Rheum Dis; 2007 Jul; 66(7):945-51. PubMed ID: 17142385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
    Cannon CP; Curtis SP; Bolognese JA; Laine L;
    Am Heart J; 2006 Aug; 152(2):237-45. PubMed ID: 16875903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
    Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
    Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis.
    Ghosh S; Paul S; Das N; Bhattacharyya TK
    J Indian Med Assoc; 2007 May; 105(5):260-2. PubMed ID: 17915794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II).
    Krueger K; Lino L; Dore R; Radominski S; Zhang Y; Kaur A; Simpson R; Curtis S
    Ann Rheum Dis; 2008 Mar; 67(3):315-22. PubMed ID: 17965424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
    Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS
    Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
    Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
    Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
    Bingham CO; Smugar SS; Wang H; Peloso PM; Gammaitoni A
    Pain Med; 2011 Mar; 12(3):352-61. PubMed ID: 21332932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.
    Gibofsky A; Hochberg MC; Jaros MJ; Young CL
    Curr Med Res Opin; 2014 Sep; 30(9):1883-93. PubMed ID: 25050589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
    Balazcs E; Sieper J; Bickham K; Mehta A; Frontera N; Stryszak P; Popmihajlov Z; Peloso PM
    BMC Musculoskelet Disord; 2016 Oct; 17(1):426. PubMed ID: 27737664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.